(Q36318159)

13 August 2017

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

1 reference

3

Lees AJ

1 reference

13 August 2017

Colzi A

1

1 reference

13 August 2017

Turner K

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

13 August 2017

1 reference

13 August 2017

64

1 reference

13 August 2017

5

1 reference

13 August 2017

573-576

1 reference

Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

The rationale for the use of dopamine agonists in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Early onset of the "on-off" phenomenon in children with symptomatic Parkinsonism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Levodopa-induced dyskinesia and thalamotomy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Pathogenesis of dyskinesias in Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

The functional anatomy of basal ganglia disorders

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Levodopa-induced dyskinesia: review, observations, and speculations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Subcutaneous apomorphine in the treatment of Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Unexpected findings with apomorphine and their possible consequences.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Subcutaneous apomorphine in Parkinson's disease

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Stereotactic ventral pallidotomy for Parkinson's disease.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Injected apomorphine and orally administered levodopa in Parkinsonism

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2170072

Control of on/off phenomenon by continuous intravenous infusion of levodopa

22 September 2018

1 reference

12 December 2020

Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease

1 reference

12 December 2020

Subcutaneous apomorphine for on-off oscillations in Parkinson's disease

1 reference

12 December 2020

The clinical use of apomorphine in Parkinson's disease

1 reference

12 December 2020

Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years

1 reference

12 December 2020

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.64.5.573

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

9598668

1 reference